Healthcare -
Biotechnology - NASDAQ - US
$ 12.05
-14.9 %
$ 178 M
Market Cap
-0.54
P/E
LYEL - NET INCOME
Net Income LYEL - Lyell Immunopharma, Inc.
-343 M
LAST VALUE
-36.86%
2 YEAR CAGR
-21.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR